What is FATE's dilution risk score?

FATE has a latest available DilutionScore record of 34/100, categorized as medium dilution risk by the DilutionWatch scoring model. DilutionWatch displays SEC filing and dilution indicators for FATE, including shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals when detected in source data.

What SEC filings does DilutionWatch track for FATE?

DilutionWatch tracks 25 SEC filing types for FATE including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect FATE shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For FATE, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for FATE tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for FATE. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

FATE Dilution Risk Score: 34/100 (MEDIUM)

Score Breakdown

📋 Offering Ability

42

💰 Cash Runway

40

📊 Float Risk

2

⚠️ Warrant Exposure

40

🔄 Convertible Debt

35

Dilution Forecast

⛅

Watch

Minor dilution signals detected

model est. 19%

🔄 Reverse Split model est. 30%

• 50-day avg $1.61 approaching $1 threshold

🔁 Convertible Conversion model 15%

• Convertible debt present: 6.0% potential dilution

🔔 Track FATE — Get forecast alerts →

Market Data

Market Cap$331.03M

Shares Outstanding119.82M

Float101.89M

Cash$153.77M

Debt$23.40M

Short InterestN/A

Institutional Holdings

QoQ: ↑ 29.4% shares (2026Q1 vs prior)

155 institutional holders · 93.98M shares

#1 Redmile Group, LLC 12.87M shares

#2 JOHNSON & JOHNSON 10.14M shares

#3 BlackRock, Inc. 10.07M shares

+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest7.68M

Days to Cover4.6

% of Float7.5%

FINRA data as of Jul 31, 2026

Insider Buy/Sell Ratio

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2013-12-31

Full SEC filing analysis available with free account →

Recent News

No recent news

Factual FATE Dilution Snapshot

Fate Therapeutics, Inc. (FATE) has a DilutionScore of 34/100, rated Medium dilution risk. Score date: August 28, 2026.

Recent SEC activity tracked for FATE: xbrl on 2013-12-31.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.